XML 57 R44.htm IDEA: XBRL DOCUMENT v3.22.4
ACQUISITIONS AND DIVESTITURES - Purchase Price Allocations (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Apr. 05, 2022
Dec. 25, 2021
Jun. 28, 2021
Mar. 30, 2021
Mar. 29, 2021
Dec. 31, 2020
Aug. 06, 2020
Jan. 03, 2020
Business Acquisition [Line Items]                  
Goodwill $ 2,849,903   $ 2,711,881            
Explora BioLabs                  
Business Acquisition [Line Items]                  
Trade receivables   $ 7,679              
Other current assets (excluding cash)   1,067              
Property, plant and equipment   37,369              
Operating lease right-of-use asset, net   48,613              
Goodwill   215,752              
Definite-lived intangible assets   70,100              
Other long-term assets   556              
Deferred revenue   (3,507)              
Current liabilities   (15,507)              
Operating lease right-of-use liabilities   (57,193)              
Deferred tax liabilities   (18,601)              
Other long-term liabilities   (1,807)              
Total purchase price allocation   284,521              
Goodwill acquired but not deductible For income taxes   $ 5,000              
Vigene Biosciences, Inc.                  
Business Acquisition [Line Items]                  
Trade receivables       $ 3,548          
Other current assets (excluding cash)       1,657          
Property, plant and equipment       7,649          
Operating lease right-of-use asset, net       22,507          
Goodwill       239,681          
Definite-lived intangible assets       93,900          
Other long-term assets       694          
Deferred revenue       (4,260)          
Current liabilities       (6,319)          
Operating lease right-of-use liabilities       (21,220)          
Deferred tax liabilities       (13,958)          
Other long-term liabilities       0          
Total purchase price allocation       $ 323,879          
Retrogenix Limited                  
Business Acquisition [Line Items]                  
Trade receivables         $ 2,266        
Other current assets (excluding cash)         209        
Property, plant and equipment         400        
Operating lease right-of-use asset, net         1,385        
Goodwill         34,489        
Definite-lived intangible assets         22,126        
Other long-term assets         0        
Deferred revenue         (434)        
Current liabilities         (1,141)        
Operating lease right-of-use liabilities         (1,205)        
Deferred tax liabilities         (4,174)        
Other long-term liabilities         0        
Total purchase price allocation         $ 53,921        
Cognate BioServices, Inc.                  
Business Acquisition [Line Items]                  
Trade receivables           $ 18,566      
Other current assets (excluding cash)           14,128      
Property, plant and equipment           52,082      
Operating lease right-of-use asset, net           34,349      
Goodwill           611,555      
Definite-lived intangible assets           270,900      
Other long-term assets           6,098      
Deferred revenue           (20,539)      
Current liabilities           (45,388)      
Operating lease right-of-use liabilities           (31,383)      
Deferred tax liabilities           (32,503)      
Other long-term liabilities           0      
Total purchase price allocation           877,865      
Estimated tax liability           $ 17,000      
Distributed Bio, Inc.                  
Business Acquisition [Line Items]                  
Trade receivables             $ 2,722    
Other current assets (excluding cash)             221    
Property, plant and equipment             2,382    
Operating lease right-of-use asset, net             1,586    
Goodwill             71,585    
Definite-lived intangible assets             24,540    
Other long-term assets             469    
Deferred revenue             (1,319)    
Current liabilities             (1,504)    
Operating lease right-of-use liabilities             (1,123)    
Deferred tax liabilities             (2,529)    
Other long-term liabilities             0    
Total purchase price allocation             $ 97,030    
Cellero, LLC                  
Business Acquisition [Line Items]                  
Trade receivables               $ 1,500  
Inventories               551  
Other current assets (excluding cash)               182  
Property, plant and equipment               1,648  
Goodwill               19,457  
Definite-lived intangible assets               16,230  
Other long-term assets               849  
Current liabilities               (1,360)  
Deferred tax liabilities               (1,467)  
Other long-term liabilities               (740)  
Total purchase price allocation               36,850  
Goodwill resulting from transaction               $ 10,800  
HemaCare Corporation                  
Business Acquisition [Line Items]                  
Trade receivables                 $ 6,451
Inventories                 8,468
Other current assets (excluding cash)                 3,494
Property, plant and equipment                 10,033
Goodwill                 210,196
Definite-lived intangible assets                 183,540
Other long-term assets                 5,920
Current liabilities                 (5,188)
Deferred tax liabilities                 (38,529)
Other long-term liabilities                 (7,664)
Total purchase price allocation                 $ 376,721